183 related articles for article (PubMed ID: 36745434)
1. A self-assembling CXCR4-targeted pyroptosis nanotoxin for melanoma therapy.
Zhao Z; Huang Y; Wang J; Lin H; Cao F; Li S; Li Y; Li Z; Liu X
Biomater Sci; 2023 Mar; 11(6):2200-2210. PubMed ID: 36745434
[TBL] [Abstract][Full Text] [Related]
2. CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma.
Rioja-Blanco E; Arroyo-Solera I; Álamo P; Casanova I; Gallardo A; Unzueta U; Serna N; Sánchez-García L; Quer M; Villaverde A; Vázquez E; León X; Alba-Castellón L; Mangues R
J Exp Clin Cancer Res; 2022 Feb; 41(1):49. PubMed ID: 35120582
[TBL] [Abstract][Full Text] [Related]
3. GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases.
Sala R; Rioja-Blanco E; Serna N; Sánchez-García L; Álamo P; Alba-Castellón L; Casanova I; López-Pousa A; Unzueta U; Céspedes MV; Vázquez E; Villaverde A; Mangues R
Drug Deliv; 2022 Dec; 29(1):1384-1397. PubMed ID: 35532120
[TBL] [Abstract][Full Text] [Related]
4. A pyroptosis nanotuner for cancer therapy.
Chen B; Yan Y; Yang Y; Cao G; Wang X; Wang Y; Wan F; Yin Q; Wang Z; Li Y; Wang L; Xu B; You F; Zhang Q; Wang Y
Nat Nanotechnol; 2022 Jul; 17(7):788-798. PubMed ID: 35606443
[TBL] [Abstract][Full Text] [Related]
5. Pyroptosis: A road to next-generation cancer immunotherapy.
Fang Y; Tang Y; Huang B
Semin Immunol; 2023 Jul; 68():101782. PubMed ID: 37302166
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic Parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity.
Lin J; Sun S; Zhao K; Gao F; Wang R; Li Q; Zhou Y; Zhang J; Li Y; Wang X; Du L; Wang S; Li Z; Lu H; Lan Y; Song D; Guo W; Chen Y; Gao F; Zhao Y; Fan R; Guan J; He W
Nat Commun; 2023 Jan; 14(1):224. PubMed ID: 36641456
[TBL] [Abstract][Full Text] [Related]
7. USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer.
Ren Y; Feng M; Hao X; Liu X; Li J; Li P; Gao J; Qi Q; Du L; Wang C; Wang Q; Wang Y
Cancer Res; 2023 Apr; 83(7):1074-1093. PubMed ID: 36607699
[TBL] [Abstract][Full Text] [Related]
8. Lighting a Fire: Gasdermin-Mediated Pyroptosis Remodels the Glioma Microenvironment and Promotes Immune Checkpoint Blockade Response.
Cai Y; Li K; Lin J; Liang X; Xu W; Zhan Z; Xue S; Zeng Y; Chai P; Mao Y; Song Z; Han L; Song Y; Zhang X; Wang H
Front Immunol; 2022; 13():910490. PubMed ID: 35784306
[TBL] [Abstract][Full Text] [Related]
9. Gasdermins: Pore-forming Proteins as a Potential Therapeutic Target.
Jain K; Barve K; Bhatt LK
Curr Protein Pept Sci; 2022; 23(3):133-151. PubMed ID: 35538820
[TBL] [Abstract][Full Text] [Related]
10. Gasdermins and cancers.
Hou J; Li T; Hsu JM; Zhang X; Hung MC
Semin Immunol; 2023 Nov; 70():101833. PubMed ID: 37647772
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic role of pyroptosis in tumor microenvironment and tumor immunotherapy.
Attar R; Qureshi MZ; Sabitaliyevich UY; Yulaevna IM; Romero MA
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):260-267. PubMed ID: 38678598
[TBL] [Abstract][Full Text] [Related]
12. Gasdermins: a dual role in pyroptosis and tumor immunity.
Yang J; Jiang J
Front Immunol; 2024; 15():1322468. PubMed ID: 38304430
[TBL] [Abstract][Full Text] [Related]
13. Logic "AND Gate Circuit"-Based Gasdermin Protein Expressing Nanoplatform Induces Tumor-Specific Pyroptosis to Enhance Cancer Immunotherapy.
Wang X; Zhang W; Wang Y; Zhu X; Liu Z; Liu M; Wu Z; Li B; Liu S; Liao S; Zhu P; Liu B; Li C; Wang Y; Chen Z
ACS Nano; 2024 Mar; 18(9):6946-6962. PubMed ID: 38377037
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of pyroptosis and its role in anti-tumor immunity.
Huang H; Weng Y; Tian W; Lin X; Chen J; Luo L
Int J Biol Sci; 2023; 19(13):4166-4180. PubMed ID: 37705746
[TBL] [Abstract][Full Text] [Related]
15. Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis.
Zhou B; Zhang JY; Liu XS; Chen HZ; Ai YL; Cheng K; Sun RY; Zhou D; Han J; Wu Q
Cell Res; 2018 Dec; 28(12):1171-1185. PubMed ID: 30287942
[TBL] [Abstract][Full Text] [Related]
16. Pyroptosis in glioma: Current management and future application.
Guo Z; Su Z; Wei Y; Zhang X; Hong X
Immunol Rev; 2024 Jan; 321(1):152-168. PubMed ID: 38063042
[TBL] [Abstract][Full Text] [Related]
17. The Therapeutic Potential of Pyroptosis in Melanoma.
Zaffaroni N; Beretta GL
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674798
[TBL] [Abstract][Full Text] [Related]
18. The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment.
Li M; Jiang P; Yang Y; Xiong L; Wei S; Wang J; Li C
Exp Hematol Oncol; 2023 Dec; 12(1):103. PubMed ID: 38066523
[TBL] [Abstract][Full Text] [Related]
19. Anti-PD-1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2-Positive Gastric Cancer through Gasdermin B-Cleavage Induced Pyroptosis.
Lin W; Zhang Y; Yang Y; Lin B; Zhu M; Xu J; Chen Y; Wu W; Chen B; Chen X; Liu J; Wang H; Teng F; Yu X; Wang H; Lu J; Zhou Q; Teng L
Adv Sci (Weinh); 2023 Oct; 10(30):e2303908. PubMed ID: 37587833
[TBL] [Abstract][Full Text] [Related]
20. Raptinal Induces Gasdermin E-Dependent Pyroptosis in Naïve and Therapy-Resistant Melanoma.
Vernon M; Wilski NA; Kotas D; Cai W; Pomante D; Tiago M; Alnemri ES; Aplin AE
Mol Cancer Res; 2022 Dec; 20(12):1811-1821. PubMed ID: 36044013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
